Epirus and Orygen strike biosimilar deal in Brazil
Mattos Filho, Veiga Filho, Marrey Jr e Quiroga Advogados and the San Diego office of Latham & Watkins LLP has helped the Swiss subsidiary of Boston-based Epirus Biopharmaceuticals enter into a collaborative agreement with Orygen Biotecnologia, bringing the biosimilar producer’s technology to the Brazilian medical market.
To read more
Subscribe to Latin Lawyer
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Latin Lawyer experts.
Subscribe now